Agency Forms Undergoing Paperwork Reduction Act Review, 49380-49381 [E9-23311]
Download as PDF
<![CDATA[
49380
Federal Register / Vol. 74, No. 186 / Monday, September 28, 2009 / Notices
cgi?P1_Prod_Version=ShockwaveFlash.
Installation questions or troubleshooting
help can be found at the same link. For
optimal viewing, a high speed Internet
connection is recommended. The
Community Banking Advisory
Committee meeting videos are made
available on-demand approximately two
weeks after the event.
Dated: September 23, 2009.
Robert E. Feldman,
Committee Management Officer,
Federal Deposit Insurance Corporation.
[FR Doc. E9–23298 Filed 9–25–09; 8:45 am]
BILLING CODE 6714–01–P
FEDERAL RESERVE SYSTEM
srobinson on DSKHWCL6B1PROD with NOTICES
Change in Bank Control Notices;
Acquisition of Shares of Bank or Bank
Holding Companies
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire a bank or bank
holding company. The factors that are
considered in acting on the notices are
set forth in paragraph 7 of the Act (12
U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the office of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than October
13, 2009.
A. Federal Reserve Bank of San
Francisco (Kenneth Binning, Vice
President, Applications and
Enforcement) 101 Market Street, San
Francisco, California 94105–1579:
1. Alma Medina Vivar, Daly City,
California; as part of a group acting in
concert including Rommel and Ruell
Medina, to individually acquire, and to
collectively acquire, voting shares of
MNB Holdings, Inc., and thereby
indirectly acquire voting shares of
Mission National Bank, both of San
Francisco, California.
Board of Governors of the Federal Reserve
System, September 23, 2009.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E9–23356 Filed 9–25–09; 8:45 am]
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR Part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than October 23,
2009.
A. Federal Reserve Bank of
Richmond (A. Linwood Gill, III, Vice
President) 701 East Byrd Street,
Richmond, Virginia 23261–4528:
1. Nantahala Bancshares, Inc.,
Franklin, North Carolina; to become a
bank holding company by acquiring 100
percent of the voting shares of
Nantahala Bank & Trust Company,
Franklin, North Carolina.
Board of Governors of the Federal Reserve
System, September 23, 2009.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E9–23357 Filed 9–25–09; 8:45 am]
BILLING CODE 6210–01–S
BILLING CODE 6210–01–S
VerDate Nov<24>2008
16:33 Sep 25, 2009
Jkt 217001
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30 Day–09–09CC]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
CDC American Recovery and
Reinvestment Act of 2009 (ARRA)
Performance Progress Report—New—
Office of the Chief Operating Officer
(OCOO), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The American Recovery and
Reinvestment Act of 2009 was signed
into law on February 17, 2009, Public
Law 111–5 (‘‘Recovery Act’’). The
purpose of this proposed data collection
is to collect quarterly performance
information for all CDC grants and
cooperative agreements funded under
the Recovery Act. This will allow CDC
to receive reports on recipient
performance measures as set forth in the
applicable Funding Opportunity
Announcement (FOA) and Notice of
Grant Award. This requirement is in
addition to the reporting requirements
of Section 1512 of the Recovery Act, set
forth by the Office of Management and
Budget (OMB) under the data collection
instrument titled ‘‘Standard Data
Elements for Reports under Section
1512 of the American Recovery and
Reinvestment Act of 2009, Public Law
111–5 (Grants, Cooperative Agreements
and Loans).’’
The form CDC proposes to use is a
modified Performance Progress Report
(SF–PPR) which was successfully
piloted by the Administration for
Children and Families (ACF). CDC
intends to use this modified form for
quarterly standard reporting of
performance measures set forth in the
applicable FOA and Notice of Grant
Award for all CDC Recovery Act funded
E:\FR\FM\28SEN1.SGM
28SEN1
49381
Federal Register / Vol. 74, No. 186 / Monday, September 28, 2009 / Notices
grants and cooperative agreements. In
addition to allowing for uniformity of
information collection, this format will
support systematic electronic collection
and submission of information. The
form contains non-personal identifying
data elements and a section for a
performance narrative.
There are no costs to respondents
other than their time. The total
estimated annual burden hours are
11,676. This estimate reflects an
increase from the 60 day notice as a
result of an increase in respondents and
adjustments to average burden hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
(estimated)
Respondents
States: Section 317 Immunization Program—Reaching More Children &
Adults ...........................................................................................................
States: Section 317 Immunization Program—Innovative Initiatives ................
States: Section 317 Immunization Program—Communication & Provider
Education .....................................................................................................
States: Section 317 Immunization Program—Strengthening the Evidence
Base .............................................................................................................
States: Healthcare Associated Infections—Emerging Infections Program .....
States: Healthcare Associated Infections—Epidemiology & Laboratory Capacity ............................................................................................................
States: Health Information Technology and Public Health ..............................
Universities: Health Information Technology Professionals in Health Care ....
States: Communities Putting Prevention to Work—Quitline Support ..............
States: Communities Putting Prevention to Work—Policy Activities ...............
States: Communities Putting Prevention to Work—Policy Implementation ....
States: Communities Putting Prevention to Work—Community Policy Activities ................................................................................................................
Communities: Communities Putting Prevention to Work—Policy Implementation .............................................................................................................
State Cancer Registries: Comparative Effectiveness Research to Enhance
Cancer Registry Data Systems ....................................................................
Universities: Comparative Effectiveness Research to Improve Prevention
and Wellness ................................................................................................
Dated: September 21, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–23311 Filed 9–25–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
srobinson on DSKHWCL6B1PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call Maryam I. Daneshvar, the
CDC Reports Clearance Officer, at (404)
639–5960 or send an e-mail to
omb@cdc.gov. Send written comments
to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
16:33 Sep 25, 2009
Jkt 217001
6
6
1,536
360
10
4
6
240
64
10
4
4
6
6
1,536
240
52
64
30
50
50
50
4
4
4
4
4
2
6
6
6
2
2
1
1,248
1,536
720
400
400
100
40
4
16
2,560
40
2
8
640
15
4
2
120
5
4
2
40
Evaluating the Quality of Interview
Data Collected by Teratology
Information Services About Pregnancy
Outcomes, Maternal and Infant Health,
Following Medication Use During
Pregnancy and Lactation—New—
National Center on Birth Defects and
Developmental Disabilities (NCBDDD),
Centers for Disease Control and
Prevention (CDC).
This data collection is based on the
following components of the Public
Health Service Act: (1) Act 42 USC 241,
Section 301, which authorizes
‘‘research, investigations, experiments,
demonstrations, and studies relating to
the causes, diagnosis, treatment, control,
and prevention of physical and mental
diseases and impairments of man.’’ (2)
42 USC 247b–4, Section 317 C, which
authorizes the activities of the National
Center on Birth Defects and
Developmental Disabilities. This section
was created by Public Law 106–310,
also known as ‘‘the Children’s Health
Act of 2000.’’ This portion of the code
has also been amended by Public Law
108–154, which is also known as the
‘‘Birth Defects and Developmental
Disabilities Prevention Act of 2003’’.
Frm 00022
Fmt 4703
Sfmt 4703
Total burden
(in hours)
4
4
Proposed Project
PO 00000
Average
burden per
response
(in hours)
64
15
Background and Brief Description
[30 Day–09–07AA]
VerDate Nov<24>2008
Number of
responses per
respondent
The use of a number of medications
during pregnancy is known to be
associated with serious adverse effects
in children. However, because pregnant
and lactating women are traditionally
excluded from clinical trials, and
because premarketing animal studies do
not necessarily predict the experience of
humans, little information is available
about the safety of most prescription
medications during pregnancy and
lactation at the time they are marketed.
Nevertheless, many women
inadvertently use medications early in
gestation before realizing they are
pregnant, and many maternal conditions
require treatment during pregnancy and
breastfeeding to safeguard the health of
both mother and infant. Currently, the
United States does not does not conduct
comprehensive monitoring for
pregnancy or infant outcomes related to
medication exposures. To try to address
these concerns, a number of
pharmaceutical manufacturers have
established pregnancy drug registries to
monitor the effects of use of selected
medications during pregnancy on
pregnancy outcomes and fetal and
infant health. In some instances, the
U.S. Food and Drug Administration has
required postmarketing monitoring of
pregnancy outcomes after medication
E:\FR\FM\28SEN1.SGM
28SEN1
]]>Agencies
[Federal Register Volume 74, Number 186 (Monday, September 28, 2009)]
[Notices]
[Pages 49380-49381]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-23311]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30 Day-09-09CC]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-5806.
Written comments should be received within 30 days of this notice.
Proposed Project
CDC American Recovery and Reinvestment Act of 2009 (ARRA)
Performance Progress Report--New--Office of the Chief Operating Officer
(OCOO), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The American Recovery and Reinvestment Act of 2009 was signed into
law on February 17, 2009, Public Law 111-5 (``Recovery Act''). The
purpose of this proposed data collection is to collect quarterly
performance information for all CDC grants and cooperative agreements
funded under the Recovery Act. This will allow CDC to receive reports
on recipient performance measures as set forth in the applicable
Funding Opportunity Announcement (FOA) and Notice of Grant Award. This
requirement is in addition to the reporting requirements of Section
1512 of the Recovery Act, set forth by the Office of Management and
Budget (OMB) under the data collection instrument titled ``Standard
Data Elements for Reports under Section 1512 of the American Recovery
and Reinvestment Act of 2009, Public Law 111-5 (Grants, Cooperative
Agreements and Loans).''
The form CDC proposes to use is a modified Performance Progress
Report (SF-PPR) which was successfully piloted by the Administration
for Children and Families (ACF). CDC intends to use this modified form
for quarterly standard reporting of performance measures set forth in
the applicable FOA and Notice of Grant Award for all CDC Recovery Act
funded
[[Page 49381]]
grants and cooperative agreements. In addition to allowing for
uniformity of information collection, this format will support
systematic electronic collection and submission of information. The
form contains non-personal identifying data elements and a section for
a performance narrative.
There are no costs to respondents other than their time. The total
estimated annual burden hours are 11,676. This estimate reflects an
increase from the 60 day notice as a result of an increase in
respondents and adjustments to average burden hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Number of Average burden
Respondents respondents responses per per response Total burden
(estimated) respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
States: Section 317 Immunization Program-- 64 4 6 1,536
Reaching More Children & Adults................
States: Section 317 Immunization Program-- 15 4 6 360
Innovative Initiatives.........................
States: Section 317 Immunization Program-- 10 4 6 240
Communication & Provider Education.............
States: Section 317 Immunization Program-- 64 4 6 1,536
Strengthening the Evidence Base................
States: Healthcare Associated Infections-- 10 4 6 240
Emerging Infections Program....................
States: Healthcare Associated Infections-- 52 4 6 1,248
Epidemiology & Laboratory Capacity.............
States: Health Information Technology and Public 64 4 6 1,536
Health.........................................
Universities: Health Information Technology 30 4 6 720
Professionals in Health Care...................
States: Communities Putting Prevention to Work-- 50 4 2 400
Quitline Support...............................
States: Communities Putting Prevention to Work-- 50 4 2 400
Policy Activities..............................
States: Communities Putting Prevention to Work-- 50 2 1 100
Policy Implementation..........................
States: Communities Putting Prevention to Work-- 40 4 16 2,560
Community Policy Activities....................
Communities: Communities Putting Prevention to 40 2 8 640
Work--Policy Implementation....................
State Cancer Registries: Comparative 15 4 2 120
Effectiveness Research to Enhance Cancer
Registry Data Systems..........................
Universities: Comparative Effectiveness Research 5 4 2 40
to Improve Prevention and Wellness.............
----------------------------------------------------------------------------------------------------------------
Dated: September 21, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E9-23311 Filed 9-25-09; 8:45 am]
BILLING CODE 4163-18-P
